Mn Services Vermogensbeheer B.V. Amgen Inc Transaction History

Mn Services Vermogensbeheer B.V.

$13.8 Billion
Q1 2024

A detailed history of Mn Services Vermogensbeheer B.V. transactions in Amgen Inc stock. As of the latest transaction made, Mn Services Vermogensbeheer B.V. holds 89,992 shares of AMGN stock, worth $28.1 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

89,992

Previous 252,692 64.39%

Holding current value

$28.1 Million

Previous $72.8 Million 64.84%

% of portfolio

0.19%

Previous 0.66%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	SELL	$268.87 - $324.56 $43.7 Million - $52.8 Million	-162,700 Reduced 64.39%	89,992 $25.6 Million
Q4 2023 Jan 29, 2024	SELL	$255.7 - $288.46 $1.92 Million - $2.16 Million	-7,500 Reduced 2.88%	252,692 $72.8 Million
Q3 2023 Oct 25, 2023	BUY	$218.65 - $271.46 $874,600 - $1.09 Million	4,000 Added 1.56%	260,192 $69.9 Million
Q2 2023 Aug 09, 2023	SELL	$214.27 - $253.37 $4.74 Million - $5.6 Million	-22,100 Reduced 7.94%	256,192 $56.9 Million
Q1 2023 Apr 26, 2023	BUY	$225.79 - $275.2 $2.28 Million - $2.78 Million	10,100 Added 3.77%	278,292 $67.3 Million

Q4 2022 Feb 03, 2023	SELL	$229.03 - $291.01 $9.32 Million - $11.8 Million	-40,700 Reduced 13.18%	268,192 $70.4 Million
Q3 2022 Nov 01, 2022	SELL	$224.46 - $253.15 $3.91 Million - $4.4 Million	-17,400 Reduced 5.33%	308,892 $69.6 Million
Q2 2022 Aug 03, 2022	SELL	$230.71 - $256.74 $20.2 Million - $22.4 Million	-87,400 Reduced 21.13%	326,292 $79.4 Million
Q1 2022 May 10, 2022	SELL	$219.27 - $242.57 $5.94 Million - $6.57 Million	-27,100 Reduced 6.15%	413,692 $100 Million
Q4 2021 Feb 10, 2022	BUY	$198.88 - $227.6 $1.83 Million - $2.09 Million	9,200 Added 2.13%	440,792 $99.2 Million
Q3 2021 Nov 03, 2021	BUY	$212.27 - $248.7 $1.72 Million - $2.01 Million	8,100 Added 1.91%	431,592 $91.8 Million
Q2 2021 Aug 05, 2021	SELL	$233.58 - $259.14 $22.3 Million - $24.8 Million	-95,600 Reduced 18.42%	423,492 $87 Million
Q4 2020 Feb 09, 2021	BUY	$216.38 - $257.67 $1.38 Million - $1.65 Million	6,400 Added 1.25%	519,092 $119 Million
Q3 2020 Nov 04, 2020	BUY	$234.65 - $260.95 $2.37 Million - $2.64 Million	10,100 Added 2.01%	512,692 $130 Million
Q2 2020 Jul 23, 2020	SELL	$197.81 - $242.74 $6.05 Million - $7.43 Million	-30,600 Reduced 5.74%	502,592 $119 Million
Q1 2020 May 12, 2020	SELL	$182.24 - $241.7 $6 Million - $7.95 Million	-32,900 Reduced 5.81%	533,192 $108 Million
Q4 2019 Feb 12, 2020	BUY	$189.21 - $243.2 $3.5 Million - $4.5 Million	18,500 Added 3.38%	566,092 $136 Million
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $39.6 Million - $47.5 Million	227,637 Added 71.15%	547,592 $106 Million
Q2 2019 Jul 25, 2019	SELL	$166.7 - $195.41 $7.87 Million - $9.22 Million	-47,200 Reduced 12.86%	319,955 $59 Million
Q1 2019 May 06, 2019	BUY	$180.87 - $203.88 $162,783 - $183,492	900 Added 0.25%	367,155 $69.8 Million
Q4 2018 Feb 12, 2019	BUY	$178.4 - $208.25 $46.4 Million - $54.2 Million	260,092 Added 244.99%	366,255 $62.4 Million
Q3 2018 Nov 02, 2018	SELL	$185.29 - $208.89 $277,935 - $313,335	-1,500 Reduced 1.39%	106,163 $22 Million
Q2 2018 Aug 13, 2018	BUY	$166.05 - $186.51 $282,285 - $317,067	1,700 Added 1.6%	107,663 $19.9 Million
Q1 2018 May 11, 2018	SELL	$169.43 - $198.0 $1.47 Million - $1.72 Million	-8,700 Reduced 7.59%	105,963 $18.1 Million
Q4 2017 Feb 02, 2018	SELL	$168.79 - $188.59 $1.16 Million - $1.3 Million	-6,900 Reduced 5.68%	114,663 $16.6 Million
Q3 2017 Nov 01, 2017	BUY	$167.29 - $191.0 $20.3 Million - $23.2 Million	121,563	121,563 $22.7 Million

Others Institutions Holding AMGN

# of Institutions

2,930

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $167B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mn Services Vermogensbeheer B.V., based on Form 13F filings with the SEC.

News

Stay updated on Mn Services Vermogensbeheer B.V. with notifications on news.

Account

Mn Services Vermogensbeheer B.V. Amgen Inc Transaction History